Development of an NF1-OPG Pig Model

This project aims to accelerate translational research by characterizing pre-clinical models including the NF1-deficient and OPG-bearing Ossabaw pig and perform pilot studies designed to determine therapeutic efficacy of top neuroprotection, regeneration, and stem cell candidate treatments.

Investigators

Jeffrey Goldberg, MD, PhD

Stanford University

School of Medicine

Jeffrey Goldberg, MD, PhD

Stanford University

School of Medicine

Current Stage

Discovery

Discovery
In Vivo Proof of Concept
IND Enabling
Clinical Trial Phase 1
Clinical Trial Phase 2
Clinical Trial Phase 3